TD SYNNEX delivered one of the more emphatic beats of the season. Non-GAAP earnings of $5.68 per share topped the $4.65 consensus by 19.8% and cleared the $4.74 Earnings Whisper number with ease. They also landed well above the company's own $4.50 guide. Revenue of $21.558 billion beat the $18.62 billion consensus by 15.8% and grew 37.7% year over year, while earnings grew 56.0%. The fourth-quarter outlook came in above estimates. On every headline measure this was a beat-and-raise. The central tension is that the growth is being bought with the balance sheet. Free cash flow was roughly negative $1 billion in the quarter, and the company's earlier cash-conversion commitment has quietly lapsed.
The quality of the earnings line holds up reasonably well. Gross margin fell 61 basis points to 6.61% as the mix shifted toward large, lower-margin infrastructure deals and Hyve manufacturing volume. Operating leverage more than compensated. SG&A rose only about 5% against 37.7% revenue growth, lifting non-GAAP operating margin 39 basis points to 3.42%. GAAP EPS was $5.18. Notably, the non-GAAP figure excludes $0.46 per share of investment dividends and gains, so the adjusted number was not flattered by that line. Rising interest expense, $120.5 million versus $91.2 million a year ago, is the first visible cost of the working-capital build.
The call made clear that the growth is broadening rather than fading. Gross billings rose 40%, extending a steady climb from 24% in Q1 and 33% in Q2. The segments showed the same pattern:
- Distribution billings growth improved to 27% from 22% and 17% in the prior two quarters.
- Advanced Solutions accelerated to 37%.
- Distribution operating margin expanded 35 basis points to 1.95%.
- Hyve billings more than doubled to $7.0 billion, up 117%.
Hyve's operating margin of 3.61% remains well below the 5.04% of a year ago, but it rose from 3.3% in Q2. Management upgraded its framing from holding margins steady to expecting modest improvement, saying the mix headwind has stabilized and new awards are neutral to accretive. There are soft spots. PC units swung from growth to a mid-to-high single-digit decline, leaving that business reliant on pricing and mix, with AI PCs now near half of PC revenue.
The catalyst list lengthened:
- A Mark III Systems agreement to support a large enterprise NVIDIA Vera Rubin NVL72 AI factory.
- An IBM expansion into 20 more countries.
- New hyperscaler programs at Hyve shipping in Q4, at the early end of the prior window.
- Co-designed liquid-cooled networking racks targeted for production in the first half of FY27.
The Q4 guide calls for billings of $31.9 billion, up 31%, and non-GAAP EPS of $5.90 at the midpoint, up 54%. A quarter ago, the Q3 guide implied just 22% billings growth. Bears still have legitimate ammunition:
- Inventories swelled to $15.3 billion from $9.5 billion at fiscal year-end.
- Net working capital reached $6.5 billion.
- The cash conversion cycle stretched to 22 days from 16 in Q1.
- Cash fell to $749 million, and net leverage climbed to 1.9x from 1.1x at the end of FY25.
The company leaned on $1.5 billion of net revolver borrowings in the quarter and trimmed buybacks to $100 million. Management frames FY26 as front-loaded investment and expects free cash flow to improve in Q4 and into FY27. That is an expectation, not a result. Hyve contracts can be cancelled, some programs won't earn full returns until the back half of FY27, and investors are openly debating a data center spending peak.
The market setup is more complicated than the surprise implies. Shares entered the report at $287.89. That is 36.1% above the 200-day moving average and just 3.6% below a 52-week high of $298.77 set the day before earnings. The stock had rallied 23% off its July low, yet it was up only 1.7% from the open following the June report. In other words, strong expectations were already embedded, and the round trip since June shows how quickly enthusiasm has come and gone. Investor sentiment remained positive but weakened meaningfully, falling from 0.39 to 0.20 heading into the release. That cooling fits the cash-flow and peak-cycle concerns more than the operating trajectory. Momentum and AVWAP readings remain positive, while the price trend is neutral.
The bottom line is that TD SYNNEX's operating story strengthened on nearly every axis this quarter: accelerating billings, a larger raise, improving Hyve margin commentary and a deeper AI pipeline. The price of that growth is a swelling working-capital burden, higher leverage and an abandoned cash-conversion target. The next leg for the story likely depends less on whether demand holds, which the call supports, and more on whether management can show in Q4 that the inventory build converts back into cash.